echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Market risk analysis of hyaluronic acid products in China

    Market risk analysis of hyaluronic acid products in China

    • Last Update: 2019-12-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Hyaluronic acid, also known as hyaluronic acid, has many important physiological functions in the body due to its unique molecular structure and physical and chemical properties According to the source of raw materials, hyaluronic acid can be divided into injection grade to prevent operation adhesion and anti-aging injection beauty; eye drop grade, a drug carrier to reduce drug stimulation and extend efficacy; external skin care products and moisturizing factors; food grade, nutritional supplement food The most outstanding is that it is the best moisturizing substance found in nature With 2% pure hyaluronic acid aqueous solution, it can firmly maintain 98% moisture Therefore, it has the most extensive application in the field of medical cosmetology According to Frost & Sullivan data, in 2018, from the perspective of raw material sales, cosmetics, food and medical grade accounted for 50%, 46% and 4% respectively; but from the perspective of raw material sales, pharmaceutical grade sales accounted for 50% of the sales, and the export price of Chinese pharmaceutical grade hyaluronic acid was 2700-50000 USD / kg, while other grades were 150-500 USD / kg High added value and high gross profit rate may attract manufacturers to make efforts to layout the pharmaceutical grade hyaluronic acid Market and become an important growth point of hyaluronic acid industry There are two main applications of hyaluronic acid in medical cosmetology, one is filling, such as chin pad, nose augmentation, and law wrinkles filling; the other is to improve skin condition, such as water light needle The new oxygen 2019 medical beauty industry white paper pointed out that the Chinese medical beauty market is currently in a high-speed development stage, and the most popular product of injectable medical beauty is hyaluronic acid, accounting for 67% In 2018, 100000 users chose chin pad project on the platform, an increase of 21.5% year on year; among the hyaluronic acid products, the fastest growth is full face filling and facial fine lines removal, 88.61% and 209% respectively The difference between the quality of imported hyaluronic acid products and domestic products is not big The difference lies in the content of adhesives and substances that cannot be absorbed by human body The content of the top-grade hyaluronic acid adhesive is slightly lower than that of the common brand, and it will be controlled within the range of a few percent to a few thousandths in general At present, domestic consumers still trust imported brands more, and the price of imported products is 50% - 80% higher than that of domestic brand products Take the best-selling Ruilan 2 as an example Its market share is about 40% Its mid-range price in mainland China is 1600 yuan, while that in Taiwan is 500 yuan High added value and high gross profit rate promote more manufacturers to distribute hyaluronic acid products Taking aimec, which specializes in producing hyaluronic acid, as an example, its operating revenue in 2016-2018 was 141 million yuan, 222 million yuan and 321 million yuan respectively, and its net profit was 53 million yuan, 77 million yuan and 118 million yuan respectively The company mainly produces three kinds of hyaluronic acid products, i.e iflay, Yimei and baonida In 2016, the gross margin of baonida reached 98.23%, and the gross margin of other products was over 85% The sales price of bonida is 2530 yuan, while the production cost is about 45 yuan The price war of hyaluronic acid products is increasingly fierce At present, the price of one hyaluronic acid in South Korea is about 600 yuan, and the price in China is about 4000 yuan, some of which have dropped by 20% - 40% With the diversification of market brands, product prices and corporate profit margins will decline.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.